Akorn launches generic antibiotic formulations

July 1, 2005

Buffalo Grove, IL—Now that patents have expired on two popular antibiotics, Akorn Inc. has launched generic versions of Alcon's Ciloxan and Ocuflox.

Buffalo Grove, IL-Now that patents have expired on two popular antibiotics, Akorn Inc. has launched generic versions of Alcon's Ciloxan and Ocuflox.

Ciprofloxacin ophthalmic solutions USP, 0.3%, and ofloxacin ophthalmic solution USP, 0.3%, were launched in the U.S. market in May. The company anticipates the combined market potential for both products to be more than $40 million.

The new products will be marketed through the company's existing distribution channels.